CD81 Promotes both the degradation of transferrin receptor 2 (TfR2) and the Tfr2-mediated maintenance of hepcidin expression

Journal of Biological Chemistry

Volumn 290, Issue 12, 2015, Pages 7841-7850

  Chen, Juxing ^a   Enns, Caroline A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION ANALYSIS; IRON; MAINTENANCE; PEPTIDES; PIGMENTS; SIGNALING;

CYTOPLASMIC DOMAINS; DOWN-REGULATION; PEPTIDE HORMONES; SIGNALING PATHWAYS; TRANS-MEMBRANE DOMAINS; TRANSFERRIN RECEPTORS; UBIQUITINATION; YEAST TWO HYBRID;

IRON COMPOUNDS;

BONE MORPHOGENETIC PROTEIN; CD81 ANTIGEN; HEPCIDIN; INHIBITOR OF DIFFERENTIATION 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN GRAIL; SMAD7 PROTEIN; TRANSFERRIN RECEPTOR 2; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; CD81 PROTEIN, HUMAN; PRIMER DNA; TFR2 PROTEIN, HUMAN; TRANSFERRIN RECEPTOR;

ARTICLE; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; GENE SILENCING; HEPCIDIN GENE; PRECIPITATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; UBIQUITINATION; UPREGULATION; CELL LINE; HUMAN; HYDROLYSIS; METABOLISM; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIGENS, CD81; BASE SEQUENCE; CELL LINE; DNA PRIMERS; HEPCIDINS; HUMANS; HYDROLYSIS; RECEPTORS, TRANSFERRIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84925308008     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.632778     Document Type: Article

References (54)

1. Feder, J. N., Gnirke, A., Thomas, W., Tsuchihashi, Z., Ruddy, D. A., Basava, A., Dormishian, F., Domingo, R., Jr., Ellis, M. C., Fullan, A., Hinton, L. M., Jones, N. L., Kimmel, B. E., Kronmal, G. S., Lauer, P., Lee, V. K., Loeb, D. B., Mapa, F. A., McClelland, E., Meyer, N. C., Mintier, G. A., Moeller, N., Moore, T., Morikang, E., Prass, C. E., Quintana, L., Starnes, S. M., Schatzman, R. C., Brunke, K. J., Drayna, D. T., Risch, N. J., Bacon, B. R., and Wolff, R. K. (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet. 13, 399-408
2. Papanikolaou, G., Samuels, M. E., Ludwig, E. H., MacDonald, M. L., Franchini, P. L., Dubé, M. P., Andres, L., MacFarlane, J., Sakellaropoulos, N., Politou, M., Nemeth, E., Thompson, J., Risler, J. K., Zaborowska, C., Babakaiff, R., Radomski, C. C., Pape, T. D., Davidas, O., Christakis, J., Brissot, P., Lockitch, G., Ganz, T., Hayden, M. R., and Goldberg, Y. P. (2004) Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat. Genet. 36, 77-82
3. Roetto, A., Papanikolaou, G., Politou, M., Alberti, F., Girelli, D., Christakis, J., Loukopoulos, D., and Camaschella, C. (2003) Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat. Genet. 33, 21-22
4. Camaschella, C., Roetto, A., Calì, A., De Gobbi, M., Garozzo, G., Carella, M., Majorano, N., Totaro, A., and Gasparini, P. (2000) The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat. Genet. 25, 14-15
5. Donovan, A., Brownlie, A., Zhou, Y., Shepard, J., Pratt, S. J., Moynihan, J., Paw, B. H., Drejer, A., Barut, B., Zapata, A., Law, T. C., Brugnara, C., Lux, S. E., Pinkus, G. S., Pinkus, J. L., Kingsley, P. D., Palis, J., Fleming, M. D., Andrews, N. C., and Zon, L. I. (2000) Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403, 776-781
6. Wallace, D. F., Pedersen, P., Dixon, J. L., Stephenson, P., Searle, J. W., Powell, L. W., and Subramaniam, V. N. (2002) Novel mutation in ferroportin1 is associated with autosomal dominant hemochromatosis. Blood 100, 692-694
7. Nemeth, E., Roetto, A., Garozzo, G., Ganz, T., and Camaschella, C. (2005) Hepcidin is decreased in TFR2 hemochromatosis. Blood 105, 1803-1806
8. Ahmad, K. A., Ahmann, J. R., Migas, M. C., Waheed, A., Britton, R. S., Bacon, B. R., Sly, W. S., and Fleming, R. E. (2002) Decreased liver hepcidin expression in the hfe knockout mouse. Blood Cells Mol. Dis. 29, 361-366
9. Bridle, K. R., Frazer, D. M., Wilkins, S. J., Dixon, J. L., Purdie, D. M., Crawford, D. H., Subramaniam, V. N., Powell, L. W., Anderson, G. J., and Ram, G. A. (2003) Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet 361, 669-673
10. Wallace, D. F., Summerville, L., Lusby, P. E., and Subramaniam, V. N. (2005) First phenotypic description of transferrin receptor 2 knockout mouse, and the role of hepcidin. Gut 54, 980-986
11. Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., and Kaplan, J. (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306, 2090-2093
12. Pigeon, C., Ilyin, G., Courselaud, B., Leroyer, P., Turlin, B., Brissot, P., and Loréal, O. (2001) A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J. Biol. Chem. 276, 7811-7819
13. Weinstein, D. A., Roy, C. N., Fleming, M. D., Loda, M. F., Wolfsdorf, J. I., and Andrews, N. C. (2002) Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease. Blood 100, 3776-3781
14. Gao, J., Chen, J., De Domenico, I., Koeller, D. M., Harding, C. O., Fleming, R. E., Koeberl, D. D., and Enns, C. A. (2010) Hepatocyte-targeted HFE and TFR2 control hepcidin expression in mice. Blood 115, 3374-3381
15. Guihard, S., Clay, D., Cocault, L., Saulnier, N., Opolon, P., Souyri, M., Pagès, G., Pouysségur, J., Porteu, F., and Gaudry, M. (2010) The MAPK ERK1 is a negative regulator of the adult steady-state splenic erythropoiesis. Blood 115, 3686-3694
16. Poli, M., Luscieti, S., Gandini, V., Maccarinelli, F., Finazzi, D., Silvestri, L., Roetto, A., and Arosio, P. (2010) Transferrin receptor 2 and HFE regulate furin expression via mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/Erk) signaling: implications for transferrin-dependent hepcidin regulation. Haematologica 95, 1832-1840
17. Wallace, D. F., Summerville, L., Crampton, E. M., Frazer, D. M., Anderson, G. J., and Subramaniam, V. N. (2009) Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload. Hepatology 50, 1992-2000
18. Ramey, G., Deschemin, J. C., and Vaulont, S. (2009) Cross-talk between the mitogen activated protein kinase and bone morphogenetic protein/hemojuvelin pathways is required for the induction of hepcidin by holotransferrin in primary mouse hepatocytes. Haematologica 94, 765-772
19. Johnson, M. B., and Enns, C. A. (2004) Diferric transferrin regulates transferrin receptor 2 protein stability. Blood 104, 4287-4293
20. Johnson, M. B., Chen, J., Murchison, N., Green, F. A., and Enns, C. A. (2007) Transferrin receptor 2: evidence for ligand-induced stabilization and redirection to a recycling pathway. Mol. Biol. Cell 18, 743-754
21. Chen, J., and Enns, C. A. (2007) The cytoplasmic domain of transferrin receptor 2 dictates its stability and response to holo-transferrin in Hep3B cells. J. Biol. Chem. 282, 6201-6209
22. Robb, A., and Wessling-Resnick, M. (2004) Regulation of transferrin receptor 2 protein levels by transferrin. Blood 104, 4294-4299
23. Chen, J., Wang, J., Meyers, K. R., and Enns, C. A. (2009) Transferrin-directed internalization and cycling of transferrin receptor 2. Traffic 10, 1488-1501
24. Levy, S., Todd, S. C., and Maecker, H. T. (1998) CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Annu. Rev. Immunol. 16, 89-109
25. Reynolds, G. M., Harris, H. J., Jennings, A., Hu, K., Grove, J., Lalor, P. F., Adams, D. H., Balfe, P., Hübscher, S. G., and McKeating, J. A. (2008) Hepatitis C virus receptor expression in normal and diseased liver tissue. Hepatology 47, 418-427
26. Lineberry, N., Su, L., Soares, L., and Fathman, C. G. (2008) The single subunit transmembrane E3 ligase gene related to anergy in lymphocytes (GRAIL) captures and then ubiquitinates transmembrane proteins across the cell membrane. J. Biol. Chem. 283, 28497-28505
27. Anandasabapathy, N., Ford, G. S., Bloom, D., Holness, C., Paragas, V., Seroogy, C., Skrenta, H., Hollenhorst, M., Fathman, C. G., and Soares, L. (2003) GRAIL: an E3 ubiquitin ligase that inhibits cytokine gene transcription is expressed in anergic CD4+ T cells. Immunity 18, 535-547
28. Vogt, T. M., Blackwell, A. D., Giannetti, A. M., Bjorkman, P. J., and Enns, C. A. (2003) Heterotypic interactions between transferrin receptor and transferrin receptor 2. Blood 101, 2008-2014
29. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685
30. Lawrence, C. M., Ray, S., Babyonyshev, M., Galluser, R., Borhani, D. W., and Harrison, S. C. (1999) Crystal structure of the ectodomain of human transferrin receptor. Science 286, 779-782
31. Nakamichi, S., Senga, Y., Inoue, H., Emi, A., Matsuki, Y., Watanabe, E., Hiramatsu, R., Ogawa, W., and Kasuga, M. (2009) Role of the E3 ubiquitin ligase gene related to anergy in lymphocytes in glucose and lipid metabolism in the liver. J. Mol. Endocrinol. 42, 161-169
32. Johnson, A. E., Audigier, S., Rossi, F., Jard, S., Tribollet, E., and Barberis, C. (1993) Localization and characterization of vasopressin binding sites in the rat brain using an iodinated linear AVP antagonist. Brain Res. 622, 9-16
33. Rocha-Perugini, V., Zamai, M., González-Granado, J. M., Barreiro, O., Tejera, E., Yañez-Mó, M., Caiolfa, V. R., and Sanchez-Madrid, F. (2013) CD81 controls sustained T cell activation signaling and defines the maturation stages of cognate immunological synapses. Mol. Cell. Biol. 33, 3644-3658
34. Carloni, V., Mazzocca, A., and Ravichandran, K. S. (2004) Tetraspanin CD81 is linked to ERK/MAPKinase signaling by Shc in liver tumor cells. Oncogene 23, 1566-1574
35. Calzolari, A., Raggi, C., Deaglio, S., Sposi, N. M., Stafsnes, M., Fecchi, K., Parolini, I., Malavasi, F., Peschle, C., Sargiacomo, M., and Testa, U. (2006) TfR2 localizes in lipid raft domains and is released in exosomes to activate signal transduction along the MAPK pathway. J. Cell Sci. 119, 4486-4498
36. Levy, S., and Shoham, T. (2005) The tetraspanin web modulates immune-signalling complexes. Nat. Rev. Immunol. 5, 136-148
37. Truksa, J., Lee, P., and Beutler, E. (2009) Two BMP responsive elements, STAT, and bZIP/HNF4/COUP motifs of the hepcidin promoter are critical for BMP, SMAD1, and HJV responsiveness. Blood 113, 688-695
38. Zona, L., Tawar, R. G., Zeisel, M. B., Xiao, F., Schuster, C., Lupberger, J., and Baumert, T. F. (2014) CD81-receptor associations: impact for hepatitis C virus entry and antiviral therapies. Viruses 6, 875-892
39. Vieira, A. V., Lamaze, C., and Schmid, S. L. (1996) Control of EGF receptor signaling by clathrin-mediated endocytosis. Science 274, 2086-2089
40. Seaman, M. N., Burd, C. G., and Emr, S. D. (1996) Receptor signalling and the regulation of endocytic membrane transport. Curr. Opin. Cell Biol. 8, 549-556
41. Carpenter, G., and Cohen, S. (1979) Epidermal growth factor. Annu. Rev. Biochem. 48, 193-216
42. Miller, K., Beardmore, J., Kanety, H., Schlessinger, J., and Hopkins, C. R. (1986) Localization of the epidermal growth factor (EGF) receptor within the endosome of EGF-stimulated epidermoid carcinoma (A431) cells. J. Cell Biol. 102, 500-509
43. Dunn, W. A., Connolly, T. P., and Hubbard, A. L. (1986) Receptor-mediated endocytosis of epidermal growth factor by rat hepatocytes: receptor pathway. J. Cell Biol. 102, 24-36
44. Lai, W. H., Guyda, H. J., and Bergeron, J. J. (1986) Binding and internalization of epidermal growth factor in human term placental cells in culture. Endocrinology 118, 413-423
45. Carpenter, G., Lembach, K. J., Morrison, M. M., and Cohen, S. (1975) Characterization of the binding of 125-I-labeled epidermal growth factor to human fibroblasts. J. Biol. Chem. 250, 4297-4304
46. Gorden, P., Carpentier, J. L., Cohen, S., and Orci, L. (1978) Epidermal growth factor: morphological demonstration of binding, internalization, and lysosomal association in human fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 75, 5025-5029
47. Lloyd, T. E., Atkinson, R., Wu, M. N., Zhou, Y., Pennetta, G., and Bellen, H. J. (2002) Hrs regulates endosome membrane invagination and tyrosine kinase receptor signaling in Drosophila. Cell 108, 261-269
48. Cottrell, G. S., Amadesi, S., Schmidlin, F., and Bunnett, N. (2003) Protease-activated receptor 2: activation, signalling and function. Biochem. Soc. Trans. 31, 1191-1197
49. Soh, U. J., Dores, M. R., Chen, B., and Trejo, J. (2010) Signal transduction by protease-activated receptors. Br. J. Pharmacol. 160, 191-203
50. Babitt, J. L., Huang, F. W., Wrighting, D. M., Xia, Y., Sidis, Y., Samad, T. A., Campagna, J. A., Chung, R. T., Schneyer, A. L., Woolf, C. J., Andrews, N. C., and Lin, H. Y. (2006) Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat. Genet. 38, 531-539
51. Babitt, J. L., Huang, F. W., Xia, Y., Sidis, Y., Andrews, N. C., and Lin, H. Y. (2007) Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. J. Clin. Invest. 117, 1933-1939
52. Wang, R. H., Li, C., Xu, X., Zheng, Y., Xiao, C., Zerfas, P., Cooperman, S., Eckhaus, M., Rouault, T., Mishra, L., and Deng, C. X. (2005) A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab. 2, 399-409
53. Verga Falzacappa, M. V., Casanovas, G., Hentze, M. W., and Muckenthaler, M. U. (2008) A bone morphogenetic protein (BMP)-responsive element in the hepcidin promoter controls HFE2-mediated hepatic hepcidin expression and its response to IL-6 in cultured cells. J. Mol. Med. 86, 531-540
54. Corradini, E., Rozier, M., Meynard, D., Odhiambo, A., Lin, H. Y., Feng, Q., Migas, M. C., Britton, R. S., Babitt, J. L., and Fleming, R. E. (2011) Iron regulation of hepcidin despite attenuated Smad1,5,8 signaling in mice without transferrin receptor 2 or Hfe. Gastroenterology 141, 1907-1914